Adial Pharmaceuticals, Inc. Paid-in-Kind Interest
Adial Pharmaceuticals, Inc. (ADIL) reported Paid-in-Kind Interest of $776.21 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-20.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:PaidInKindInterest · last filed 2020-03-20
- Adial Pharmaceuticals, Inc. paid-in-kind interest for the quarter ending 2018-12-31 was $30.55K.
- Adial Pharmaceuticals, Inc. paid-in-kind interest for fiscal 2018 was $776.21K.
| Period end | Paid-in-Kind Interest 3 month | Paid-in-Kind Interest 9 month | Paid-in-Kind Interest 12 month |
|---|---|---|---|
| 2018-12-31 | $30.55K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-20 | $776.21K 10-K · filed 2020-03-20 | |
| 2018-09-30 | $745.66K 10-Q · filed 2019-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |